Abbott Vascular Devices (Redwood City, CA) received FDA approval earlier this month for its Xact carotid stent and Emboshield embolic protection system. The device is intended to treat carotid artery ...
Cardiovascular Systems Inc (CSI) has recalled its Wirion embolic protection device (Wirion) due to complaints that the filter may break during retrieval, according to a notice posted on the US Food ...
The recall was initiated following reports of 9 device malfunctions. Cardiovascular Systems Inc. has issued a voluntary recall of unused WIRION ® Embolic Protection systems due to complaints of filter ...
TAVR is a less invasive cardiac procedure that treats patients with severe aortic stenosis without open heart surgery. While TAVR represents a major advance for patients, it carries a small but ...
Less than a year after debuting its Wirion embolic protection system, Cardiovascular Systems is recalling all of the devices manufactured and distributed between January and November 2021. The Wirion ...
(MENAFN- EIN Presswire) EINPresswire/ -- The Embolic Protection Devices Market is gaining significant traction globally, driven by the rising prevalence of cardiovascular diseases, increasing adoption ...
United States Embolic Protection Device Market is expected to reach US$ 650 million by 2033 from US$ 360 million in 2024, with a CAGR of 6.96% from 2025 to 2033. Rising cardiovascular operations, ...
Stroke remains a problem after TAVR and continues to feed discussions around how extensively cerebral embolic protection devices and other strategies should be used. In a session during TVT Connect, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results